Here, we demonstrated the existence of an important regulatory axis in the tumor microenvironment involving the upregulation of BMP2 by RUNX1, which in turn activates the PI3K-AKT signaling pathway, subsequently promoting EMT and VM, both of which ultimately promote the malignant progression of LSCC. Here, RUNX1 is linked to neoplasm.